Pharmacology News

Remote BP monitoring and collaborative telehealth visits with a pharmacist improved BP control among patients at rural nephrology clinics and reduced hospitalization, a speaker reported.

Tirzepatide is associated with similar odds for gastrointestinal adverse events and a lower likelihood for diabetic retinopathy and pancreatitis compared with GLP-1 receptor agonists, according to a presenter.

Patients with past-month exposure to prescription amphetamines used to treat ADHD had higher odds of developing psychosis or mania compared with those without past-month exposure, according to a recent study.

A novel oral GLP-1 receptor agonist was well-tolerated and linked with weight loss compared with placebo in healthy adults with overweight or obesity, according to top-line results of a phase 1 study.

A polypill containing multiple blood pressure-lowering drugs may be an effective solution to addressing both uncontrolled hypertension and polypharmacy causing non-adherence to antihypertensive medications, speakers reported.

The timing of when a patient takes their blood pressure medication does not appear to matter for reducing CV event risk, according to two trials and a meta-analysis presented at the European Society of Cardiology Congress.

Placebos administered without deception, or nondeceptive placebos, may offer an alternative and effective way to help people manage prolonged stress, according to a study published in Applied Psychology: Health and Well-Being.

High BMI eligibility for semaglutide could cost Medicare up to $145 billion annually, a brief report published in the Annals of Internal Medicine revealed.

The FDA on Thursday announced that it has greenlit the updated COVID-19 vaccines manufactured by Moderna and Pfizer-BioNTech, which the companies said should be available within days.